New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
about
Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient miceX-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms.In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancerTolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.Unraveling the pathophysiology of Sjogren syndrome-associated dry eye diseaseLocation of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome.Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndromeSensory neuronopathy and autoimmune diseasesImpact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific DiseasesIdentification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.Sjögren's syndrome: an old tale with a new twistTreatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.Mechanisms That Shape Human Antibody Repertoire Development in Mice Transgenic for Human Ig H and L Chain Loci.Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and micePolyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.Primary Sjogren's syndrome in men.The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren's syndrome and systemic sclerosis.Link between inflammation and aquaporin-5 distribution in submandibular gland in Sjögren's syndrome?
P2860
Q30414128-B3EC2FD9-C378-4BEA-BD40-CB42F22765B0Q30434942-675C41CC-B9D7-4DF4-9605-DF74A3C701DDQ33287471-723109A8-3BD4-4AFD-BB4C-31951A3B2290Q33372523-C1645C58-D0FF-4BBA-9FBA-9C48F1C642D5Q33771577-5951EFF0-528B-4F4E-A215-E5793656E731Q33819490-27958400-FB17-49ED-BFC7-194FA86CB2DDQ33862541-83F9FEB5-E70B-4A14-AC90-3900BC642703Q35535151-6C753989-74D1-4E15-84F6-941C772CBD2CQ35726020-BB895150-9DE3-4E20-B6F3-EA366E3A7257Q35840846-73FD1DF9-744D-4867-9D75-710E2CF0D7D9Q36983628-3DB755AD-424B-4730-A1C5-155FD784B129Q37129577-52C1E77C-C57E-4E9A-A3B4-402A23668868Q37206991-B86BCD74-46BF-42C7-9A61-473B6923F507Q37257149-AF836760-D18F-489C-97E2-3126328310B3Q37912214-82DEECFE-D014-4D7D-A8E2-8F3EC215414BQ38186111-3ABEFC1F-FFD6-4F41-AD62-C4798D9D60E0Q38822065-51549416-EB5D-4861-9545-5E6A1A473C92Q38829486-39200379-3916-441F-808C-4A426E9F604BQ39912433-232FC550-47AD-4D86-8140-34BB2486953DQ40081775-4501C1DC-171A-47D3-BB87-BEC5D26BAC3AQ40225870-B58AF015-269B-4737-8EF4-BAAC1A4FF0CDQ51694730-52047A26-2828-4CC3-B321-766C9B4C8957Q53666361-2A2D1024-4F3A-43B5-A302-8E27E369239FQ54530879-41E2277F-550B-4ECC-A271-A5A91236D2F9
P2860
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@ast
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@en
type
label
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@ast
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@en
prefLabel
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@ast
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@en
P2093
P1476
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers.
@en
P2093
Arne Hansen
Peter E Lipsky
Thomas Dörner
P304
P356
10.1097/00002281-200309000-00007
P577
2003-09-01T00:00:00Z